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Since its discovery over four decades ago, somatostatin (SOM) receives growing
scientific and clinical interest. Being localized in the nervous system in a subset of
interneurons somatostatin acts as a neurotransmitter or neuromodulator and its role
in the fine-tuning of neuronal activity and involvement in synaptic plasticity and memory
formation are widely recognized in the recent literature. Combining transgenic animals
with electrophysiological, anatomical and molecular methods allowed to characterize
several subpopulations of somatostatin-containing interneurons possessing specific
anatomical and physiological features engaged in controlling the output of cortical
excitatory neurons. Special characteristic and connectivity of somatostatin-containing
neurons set them up as significant players in shaping activity and plasticity of the
nervous system. However, somatostatin is not just a marker of particular interneuronal
subpopulation. Somatostatin itself acts pre- and postsynaptically, modulating excitability
and neuronal responses. In the present review, we combine the knowledge regarding
somatostatin and somatostatin-containing interneurons, trying to incorporate it into
the current view concerning the role of the somatostatinergic system in cortical
plasticity.
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INTRODUCTION
Over forty years ago, scientists discovered a small 14 amino-acid-long peptide that was able to
inhibit the release of growth hormone from the hypothalamus. They called it somatotropin release
inhibiting factor (SIRF) or somatostatin (SOM or SST; Krulich et al., 1968; Brazeau et al., 1973).
It was quickly established that SOM is present also beyond hypothalamus, across many regions of
central and peripheral nervous system, but also in non-neuronal tissues, like gastrointestinal tract
and endocrine pancreas or thyroid. Later, a number of additional SOM synthesis sites have been
identified and included the placenta, kidney, retina and cells of the immune system (Patel, 1999).
Generally, the function of SOM is to inhibit the release of several biologically active
substances, like: growth hormone, insulin, glucagon, gastrin, secretin, cholecystokinin
(Thorner et al., 1990; Herzig et al., 1994; Lloyd et al., 1997; Yao et al., 2005; Rutter, 2009;
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Chey and Chang, 2014; respectively). However, in the nervous
system it is localized in considerable proportion of GABAergic
neurons acting as neurotransmitter or neuromodulator
(Reichlin, 1995). In the scientific reports somatostatin is often
treated just as a marker for particular GABAergic interneuronal
subpopulation. However, somatostatin itself acts pre- and
postsynaptically, modulating excitability and neuronal responses.
Special characteristics and connectivity of somatostatin-
containing neurons set this neuronal subpopulation up as a
significant player in shaping activity and plasticity of the nervous
system. In this review we combine the knowledge regarding
somatostatin and somatostatin-containing interneurons, trying
to incorporate it into the present view concerning the role of
somatostatinergic system in cortical plasticity.
SOMATOSTATIN
Somatostatin, as many other hormones, is synthesized as a part
of larger prohormone-preprosomatostatin, and then undergoes
proteolytic cleavage to produce one of two active forms referring
to as SS-14 and SS-28, which reflects their amino acid chain
length (Schally and Meyers, 1980). Which and in what amount
a particular form is secreted depends on the tissue, since both
forms have different biological potency for inhibition of different
substances. For example, SS-14 is predominant in the nervous
system, whereas SS-28 ismore biologically active in the endocrine
pancreas. The longer form SS-28 can be further processed to
SS-14 (Schally and Meyers, 1980).
Physiological action of somatostatin is mediated by a
family of structurally related proteins which have different
pharmacological properties and distinct pattern of expression
in the central nervous system and peripheral tissues (Bruno
et al., 1992). Somatostatin receptors, known as SSTR1 to SSTR5
(Patel et al., 1994) were cloned in the early 1990’s and they all
belong to a family of G protein-coupled receptors. As all the
G-coupled receptors, they have seven transmembrane domains
and are encoded by separate genes segregated on different
chromosomes.
The localization and distribution of SOM receptors in
the CNS and periphery depend on tissue and species. They
are widely distributed in many tissues, with distinct but
overlapping expression pattern, often as multiple subtypes
coexisting in the same cell (Kossut et al., 1989). The five
receptors share common metabotropic signaling pathways, such
as inhibition of adenylyl cyclase, activation of phosphotyrosine
phosphatase, and modulation of mitogen-activated protein
kinase (MAPK). Some of the subtypes are also coupled to
voltage-dependent Ca2+ channels (SSTR1, 2), inward rectifying
K+ channels (SSTR2, 3, 4, 5), Na+/H+ exchanger (SSTR1),
phospholipase C (SSTR2, 5), phospholipase A2 (SSTR4),
AMPA/kainate glutamate channels (SSTR1, 2; Patel, 1999;
Table 1).
Although different somatostatin receptor subtypes SST1-
SST5 show overlapping distributions, they have also a high
degree of specialization with regard to their subcellular
targeting. While SSTR2 and SSTR4 mediate mainly postsynaptic
responses, SSTR1 is poised to modulate presynaptic responses.
In contrast, the SSTR3 appears to be excluded from classical
synaptic localization and is selectively targeted to neuronal
cilia (Schulz et al., 2000). All five receptors SSTR1–5 have
been shown to be expressed in many regions of the fetal
rodent brain with SSTR2 being predominant (Bologna and
Leroux, 2000). In postnatal rat brain particular receptors achieve
their peak expression sequentially: SSTR1 in P4-P7; SSTR3
and 5 in P7-P14 and SSTR4 around P21. In adult cortex
SSTR1 and SSTR2 dominate, each exhibiting a particular
distribution pattern across the cortical layers (Bologna and
Leroux, 2000).
Among the biological effects of SOM are hindering of
secretion, achieved by inhibition of exocytosis through
decreasing cAMP production; induction of cell cycle arrest
via modulation of MAPK (SSTR1, 2, 4, and 5); triggering
apoptosis by activation of p53 and the pro-apoptotic protein
Bax (SSTR3). Some biological responses display a selectivity
for particular receptor subtype: growth hormone secretion
regulation (SSTR2 and 5), insulin secretion (SSTR5), glucagon
secretion (SSTR2), and immune responses (SSTR2; Patel, 1999;
Table 1).
In CNS, somatostatin functions as a neurotransmitter or
neuromodulator with mainly inhibitory action. It is also an
important regulator of cell proliferation and differentiation
(Viollet et al., 2008). In the cerebral cortex, somatostatin
is a co-transmitter of GABAergic inhibitory neurons. As a
co-transmitter it can modulate the activity of the surrounding
neurons. Neuropeptides which are co-transmitters differ
from classical neurotransmitters in size and mechanism of
action. They act slower than the classical neurotransmitters
and are involved in supporting a fine-tuning of neuronal
signaling. It was shown that GABAergic interneurons which
express neuropeptides are targeted by catecholaminergic
and serotoninergic afferents with different preferences,
suggesting their role in modulation of emotional and cognitive
processes. Somatostatin-containing neurons are innervated
by noradrenergic and serotoninergic fibers (Paspalas and
Papadopoulos, 1999, 2001), but they are also affected by other
neuromodulators, especially acetylcholine, which acting via
intracortical pathways directly facilitates their activity (Chen
et al., 2015). However, acetylcholine can also regulate the activity
of SOM neurons indirectly, through basal forebrain cholinergic
activation of VIP-containing interneurons, which contact and
inhibit SOM interneurons (Letzkus et al., 2011; Jackson et al.,
2016).
Control of SOM Release
Early observations by Gamse et al. (1980), revealed that
somatostatin is released from cultured hypothalamic cells even in
the absence of exogenous stimuli, in calcium- dependentmanner.
Tapia-Arancibia and Astier (1989) showed that increase of SOM
release is achieved by membrane depolarization. Fontana et al.
(1996) have shown that in hippocampus, glutamate can stimulate
somatostatin release through the activation of ionotropic NMDA
and AMPA receptors; furthermore, experiments by Rage et al.
(1994) revealed that in primary cultures of hypothalamic neurons
release of somatostatin was elicited by NMDA application.
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TABLE 1 | Properties and distribution of somatostatin (SOM) receptors.
SSTR1 SSTR2 SSTR3 SSTR4 SSTR5
Affinity for
SS14 and SS28
SS14 = SS28 SS14 = SS28 SS14 = SS28 SS14 = SS28 SS14 < SS28
Synaptic
localization
Mainly presynaptic Postsynaptic Extrasynaptic
(neuronal cilia)
Postsynaptic postsynaptic
Transducer Gi/Go family Gi/Go family
Gq/G11 family G
protein
independent
mechanism
Gi/Go family
Gq/G11 family
Gi/Go family Gi/Go family
Gq/G11 family
Effectors AC; PTP; PLC
NHE1
AMPA/kainate
CA2+ channels
K+ channels
AC; PTP; PLC
PLD; MAPK
AMPA/kainate
CA2+ channels
K+ channels
AC; PTP; PLC
MAPK, NHE1
K+ channels
AC; PTP; PLC
MAPK; NHE1 PLA
CA2+ channels
K+ channels
AC; PTP; PLC
MAPK;
CA2+ channels
K+ channels
Distribution
in the Brain
High level:
amygdala cortex
hippocampus
hypothalamus
Medium level:
cerebellum
midbrain spinal
cord striatum
thalamus
High level:
amygdala, cortex,
hippocampus
hypothalamus
Medium level:
cerebellum
midbrain striatum
spinal cord
thalamus
High level:
amygdala
cerebellum cortex
hippocampus,
olfactory bulb
striatum
Medium level:
hypothalamus
midbrain preoptic
area thalamus
Medium level:
amygdala
cerebellum cortex
hippocampus
olfactory bulb
preoptic area
High level:
hypothalamus
preoptic area
Medium level:
amygdala
cerebellum cortex
hippocampus
striatum
Abbreviations: AC - adenylate cyclase; MAPK - mitogen-activated protein kinases; NHE1 - Na+/H+ exchanger; PLA - phospholipase A; PLC - phospholipase C;
PLD - phospholipase D; PTP - protein tyrosine phosphatase. Reference: Moller et al. (2003) and Alexander et al. (2015).
GABA was shown to inhibit spontaneous release of SOM
(Gamse et al., 1980). This result was further specified by Llorens-
cortes et al. (1992) who, by stimulating GABAA receptors in vivo
with muscimol and diazepam, have shown that it decreased SOM
content in mouse hypothalamus and cortex.
Effect of SOM Release
Somatostatin, like other neuropeptides, is stored in dense-core
vesicles residing away from the active zone in contrast to the
classical neurotransmitters localized in small synaptic vesicles
within the active zone. Dense-core vesicles require repetitive
action potentials at high frequencies to release neuropeptides and
due to large size neuropeptides diffuse through the fusion pore
slower than classical neurotransmitters. Moreover, the receptors
for neuropeptides are often in some distance from the release
site and there are no selective reuptake mechanisms. Thus,
somatostatin acts slower and its effects are longer lasting when
compared with classical neurotransmitters (Baraban and Tallent,
2004).
Somatostatin can exert its modulatory effect pre- or
postsynaptically. However, results concerning the direction and
mechanisms of somatostatin effect on synaptic transmission are
conflicting, although most studies reported its inhibitory effect.
Many of them showed that SOM inhibits excitatory synaptic
transmission and neuronal excitability showing silencing or
hyperpolarizing effect of somatostatin in hypothalamus, spinal
cord, hippocampus or cerebral cortex (Pittman and Siggins,
1981; Grilli et al., 2004). Somatostatin is also able to decrease
GABA release, as was shown in thalamus, forebrain and striatum
(Leresche et al., 2000; Momiyama and Zaborszky, 2006; Lopez-
Huerta et al., 2008). Moreover, an activity-dependent release of
SOM in hippocampal cultures resulted not only in reduction
of mEPSCs frequency, but also in the number of dendritic
spines and in the density of pre- and postsynaptic markers
of excitatory synapses (Vglut-1 and GluR2). Thus, beside
modulation of neuronal activity, SOM can also regulate the
morphology and function of excitatory synapses (Hou and Yu,
2013).
However, there were also studies reporting excitatory effects
of SOM (Olpe et al., 1980; Delfs and Dichter, 1983). Also,
facilitatory effect of SOM on the generation of LTP in
hippocampus viamodulation ofmuscarinic cholinergic receptors
was shown by Nakata et al. (1996). Gardette et al. (1995)
showed in dissociated hypothalamic neurons that somatostatin
was able to increase or decrease glutamatergic responses of
developing neurons and these effects changed with time.
Thus, somatostatin could modulate glutamate sensitivity of
hypothalamic neurons with either synergistic or antagonistic
effect, which was dependent on the activated receptor subtype.
On the other hand, Delfs and Dichter (1983) showed, that
the effect of SOM, applied to cortical neurons in culture,
can be dose dependent with smaller dose inducing excitation
and higher dose being inhibitory. Mancillas et al. (1986)
using single-unit recordings in hippocampus and parietal
cortex have noticed that when applied alone, somatostatin had
inhibitory effect on spontaneous firing of pyramidal neurons,
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but if applied together with small amounts of acetylcholine it
caused a dose dependent enhancement of acetylcholine-induced
facilitation. In summary, acting presynaptically, somatostatin
is able to decrease neurotransmitter release, which would
diminish the input on the principal neurons, while postsynaptic
action of SOM results most often in hyperpolarization of the
target neuron, inducing a slow but long-lasting inhibition.
However, acting synergistically with other neurotransmitters,
somatostatin can reverse the direction of its effect suggesting
a complexity of possible effects of somatostatin at a cellular
level.
Development
Cumulative evidence suggests that in brain development,
somatostatin itself, plays a role as a trophic or apoptotic
factor, influencing synaptogenesis, proliferation of cerebellar
neuroblasts and axonal pathfinding (Gonzalez et al., 1992;
Ferriero et al., 1994). Somatostatin-containing neurons,
participate in regulation of infragranular cortex assembly and
functional maturation (Tuncdemir et al., 2016).
During development, interneurons incorporate into the six-
layered neocortex in an inside-out fashion. In rodents, majority
of cortical interneurons is produced in the ventral telencephalon
in the medial, lateral and caudal ganglionic eminences (Marin
et al., 2001) as well as in the preoptic area (Gelman et al.,
2009) and then they tangentially migrate into developing
cortex. Already at these prenatal stages, pyramidal neurons
are integrated into transient GABAergic networks, which then
mature gradually during the first postnatal weeks (Luhmann
et al., 2014). The prevalent early-born cortical interneuron
populations include SOM and parvalbumin (PV) interneurons
(Tuncdemir et al., 2016). It was discovered that distinct
ganglionic eminences give rise to phenotypically different
subgroups of cortical interneurons and so medial ganglionic
eminence (MGE) produces approximately 70% of neocortical
interneurons with SOM interneurons being produced in dorsal
MGE and PV interneurons in ventral MGE (Xu et al., 2004; Rudy
et al., 2011; Le Magueresse and Monyer, 2013). However, despite
their common embryonic origin, SOM neuronal progenitors
represent the earliest interneuronal population migrating to
deep layers of cortical plate as early as E17.5 (Miyoshi and
Fishell, 2011), while development of PV neurons innervation
extends into later postnatal stages (Daw et al., 2007). Early-
born SOM neurons localize mainly in 5/6 cortical layer and
often persist throughout development. They receive dense
transient thalamocortical innervation and provide an input to
the excitatory neurons and inhibitory PV-containing neurons
during the first postnatal week. Later on, they develop into
typical adult-like L5/6 SOM interneurons (Tuncdemir et al.,
2016).
Hogan and Berman (1993) observed postnatal development
of somatostatinergic neurons in visual cortex of cat. They have
shown that at 1 week of age, SOM-IR neurons were only found
in deep layers of the developing cortex. By 2 weeks of age,
SOM-IR neurons were found in layer 4 (L4) and 1 week later,
they were located in all layers of the cortex except L1. Similar
developmental pattern was seen by Bendotti et al. (1990) for
preprosomatostatin mRNA in mouse cerebral cortex and by
Papadopoulos et al. (1993) for protein in visual areas of rat. SOM
neurons were visible from first postnatal week, then appeared to
increase in numbers up to about 3 weeks and thereafter decline
dramatically to adult levels, which were 14–19% of the peak
levels.
In neonatal rat brain SOM cells were detected even at P0
and were located in region of subcortical plate, but from the
end of the first postnatal week they were visible across all
cortical layers. Their number increased significantly up to the
3–4th postnatal week (Lee et al., 1998). Other studies showed
that SOM is expressed by some interneuron progenitors in the
cerebral murine cortex and in migrating populations in the
ventrolateral cortex at birth (Mukhopadhyay et al., 2009). On
the other hand, Ouellet and de Villers-Sidani (2014) showed
somatostatin expression in rat auditory cortex not earlier than
between P9 and P20.
Distribution
In adult animals, somatostatin is widely distributed in the
whole rodent brain except the cerebellum. Dense population of
somatostatin-containing cell bodies were found in neocortex,
hippocampus, amygdala, piriform cortex, nucleus caudatus,
nucleus accumbens, hypothalamus, striatum, olfactory regions
and the brainstem (Epelbaum et al., 1994; Tomioka et al., 2005).
Within neocortex, there are two main types of somatostatin-
containing neurons: Martinotti cells reaching terminal branches
of the apical dendrites of neocortical pyramidal cells in L1 and
nest and small basket cells with axonal ramification limited
to one layer (Druga, 2009). Martinotti cells are localized in
superficial (L2/3) and deep (L5/6) cortical layers (Markram
et al., 2004; Wang et al., 2004; Ma et al., 2006) whereas small
basket cells can be found in all cortical layers, but majority
is localized in L4 of cerebral cortex (Kawaguchi and Kubota,
1997; Markram et al., 2004; Ma et al., 2006; Viollet et al.,
2008).
SOM-CONTAINING NEURONS IN
CEREBRAL CORTEX
In cerebral cortex, somatostatin is usually co-localized with
gamma-aminobutyric acid (GABA), the main inhibitory
neurotransmitter. Some recent articles claim almost complete
colocalization (Kubota et al., 1994; Uematsu et al., 2008).
Others however, report some proportion of SOM neurons
which seems not to express GABAergic markers and there is
no consistency how big this population can be. Some authors
reported relatively small number of SOM+/GABA− cells,
amounting to 3–20% in rat hippocampus and cortex, (Kosaka
et al., 1988; Gonchar et al., 2007), while in other observations
this group was much bigger: −40 to 70% in the entorhinal
cortex and amygdala (Wouterlood and Pothuizen, 2000;
McDonald and Zaric, 2015). However, since those estimations
were made on the basis of immunostaining co-localization of
different GABAergic markers and SOM, there is a possibility
of underestimation if some of them is below the detection
threshold.
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Inhibitory (GABAergic) neurons, although comprise only
10–20% of cortical neurons, form very heterogeneous group
concerning their chemistry, morphology, electrical properties
and synaptic connectivity. They not only control the overall
cortical activity level, but also determine the timing of action
potential firing and regulate the postnatal development of
neuronal circuitry (Markram et al., 2004).
The specific functions of cortical GABAergic interneurons
are accomplished through an astonishing diversity of subgroups
which can be distinguished using different determinants:
somatodendritic morphology, chemical and genetic markers,
functional properties and connectivity (Kubota and Kawaguchi,
1994; Kawaguchi and Kubota, 1997; Ascoli et al., 2008). One
of such categorization can be made on the basis of the
expression of other molecules (neuropeptides, calcium binding
proteins (CBPs), neuronal nitric oxide synthase (nNOS); Kubota
et al., 1994, 2011; Uematsu et al., 2008; Kubota, 2014). Since
these markers are often closely correlated with morphology
or physiology of neuronal group in which they are expressed,
they can serve as a tool for characterization and classification.
Commonly used markers for classification of GABAergic
interneurons are PV, SOM, calretinin (CR), calbindin (CB),
vasoactive intestinal peptide (VIP), 5HT3a receptor, substance
P receptor, neuropeptide Y (NPY), cholecystokinin and cholin
acetyltransferase (Kubota et al., 1994, 2011; Markram et al.,
2004; Xu et al., 2004; Ascoli et al., 2008; Rudy et al.,
2011).
In the neocortex, somatostatin containing group of
interneurons constitutes about 20–30% of GABAergic neurons,
being the second largest subpopulation after PV expressing
neurons (40–50%; Uematsu et al., 2008; Rudy et al., 2011).
Those two groups are nonoverlapping, in frontal, somatosensory
and visual cortex of mouse (Xu et al., 2010) as well as in rat
visual cortex. However, there are reports that clearly show
colocalization of SOM and PV in mouse and rat hippocampus
(Jinno and Kosaka, 2000), mouse subiculum and olfactory
bulb (Lepousez et al., 2010; Nassar et al., 2015). About 20%
of SOM neurons co-express other markers of GABAregic
interneurons: CB, CR, NPY, substance P receptors or nNOS
(Gonchar et al., 2002; Markram et al., 2004; Endo et al.,
2016).
Overall, SOM positive neurons comprise 1–3% of
neocortical neurons and they are a heterogeneous group with
different expression of CBPs and diverse electrophysiological
characteristics. In this group mostly multipolar, but also bipolar
and fusiform neurons can be found. Somatostatin expression was
found in Martinotti cells, in a limited fraction of small and nest
basket cells and has also been detected in some double-bouquet
and bi-tufted cells (Wang et al., 2004; Ma et al., 2006). Although
somatostatin cells are called dendrite-preferring interneurons,
since they innervate mainly shafts and spines of basal and apical
dendrites of pyramidal neurons, their axons can also make
axo-somatic as well as axo-axonic synapses (Gonchar et al.,
2002).
Despite the fact that interneurons are usually short-range
neurons, providing local connections, several investigations
delivered evidence that in many species (monkeys, rodents,
carnivores) a small number of inhibitory neurons establish
long-range cortico-cortical connections (Tomioka et al.,
2005). They connect different cortical areas both ipsilaterally
and contralaterally and are involved in synchronization of
rhythmic activity between distant cortical areas, serving
to coordinate large-scale network activity (Melzer et al.,
2012; Caputi et al., 2013). Most of them are classified
as somatostatin, nNOS and NPY containing GABAergic
neurons (Tomioka et al., 2005; Higo et al., 2007; McDonald
and Zaric, 2015). Tomioka et al. (2005) found also that
cortico-striatal GABAergic projection is constituted mainly
by somatostatin positive, nNOS negative neurons which
may be neurochemically distinct from cortico-cortical
group. Considering that both cortico-cortical and cortico-
striatal GABAergic projection neurons are subpopulations
of somatostatinergic cortical neurons, it is likely that
their chemical, morphological and electrical properties
are characteristic for unique neuronal networks, to which
they belong.
SOM IN BRAIN PATHOLOGY
There is robust evidence that alterations in somatostatin
level, somatostatin-containing neurons and SOM receptors are
associated with many pathological conditions like epilepsy,
neuropsychiatric and neurodegenerative disorders (Lin and
Sibille, 2013).
Epilepsy is one of the most common neurological disorders
characterized by the occurrence of recurrent, unprovoked
seizures caused by an alteration of the subtle balance between
excitation and inhibition in the brain. It is unclear if
distinct types of interneurons are selectively involved in the
generation of epileptiform activity, but SOM interneurons
are susceptible to seizures-induced death and a decline of
SOM containing neurons is regarded as a hallmark of
epileptic hippocampus (Clynen et al., 2014). Loss of SOM
neurons has been confirmed in virtually all models of
acquired epilepsy, including kindling, status epilepticus and
traumatic brain injury models (Houser, 2014). There are
data showing that application of SOM or its receptor SSTR2
agonist reduced the severity and duration of seizures, while
somatostatin antiserum had proepileptic effects (Tallent andQiu,
2008).
Decreased level of SOM in cerebro-spinal fluid (CSF) of
patients with major depressive disorder was confirmed in several
studies and examination of human post-mortem brains revealed
region-specific somatostatin deficits in prefrontal and anterior
cingulate cortex as well as in amygdala (Tripp et al., 2011; Lin
and Sibille, 2013).
Alterations in somatostatinergic system were reported also in
other neuropsychiatric disorders. In schizophrenia a reduction
of CSF somatostatin, decreased SOM gene expression in
prefrontal cortex and reduced density of SOM+ neurons in
the entorhinal cortex and hippocampus was shown Benes
(2015). In bipolar disorder, which characterizes with mood
fluctuation, an increased CSF SOM was observed during manic
periods while a decline of SOM interneurons was reported
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in hippocampus and entorhinal cortex (Konradi et al., 2011).
Thus, changes of SOM cerebrospinal fluid level are state-
dependent and seem not to be specific for any particular
disorder.
Alzheimers disease (AD) is one of the most common
neurodegenerative disease attacking the brain and leading to
dementia. It is characterized by the presence of two kinds of
microscopic lesions called senile plaques and neurofibrillary
tangles. Davies et al. (1980) have shown that in AD patients
concentration of SOM in cortex and hippocampus was lower
than in healthy subjects. Later it was shown that the SOM
deficiency correlated with the illness severity and cognitive
deficits (Epelbaum et al., 2009). Saito et al. (2005) identified
SOM as a positive modulator of activity of neprilysin- an
enzyme involved in Aβ degradation. He suggested, that
decrease of SOM expression can act as a trigger for Aβ
accumulation contributing to late-onset sporadic AD. However,
Dournaud et al. (1995), did not find close relationship between
somatostatin deficit and neuropathology of AD and Martel
et al. (2015) showed an enrichment of SOM neurons and
fibers in olfactory peduncle and cortex of human postmortem
brains.
Thus, some authors indicate alterations of SOM as a
strong marker of AD pathology others however, suggest that
considering interaction of cholinergic pathways with SOM
interneurons, the changes observed in somatostatinergic system
in AD might be secondary to the degeneration of cholinergic
afferents from the nucleus basalis, which possess SOM
receptors.
Indisputable, reduction of cortical SOM concentrations
is not restricted to AD but is associated also with other
neurodegenerative diseases related to cognitive dysfunctions,
including Parkinson’s disease (Jiménez-Jiménez et al., 2014)
and multiple sclerosis (Roca et al., 1999). Taken together,
the presented results suggest that somatostatin alterations
are common features of many neurological disorders and
diseases, thus its direct involvement in induction of particular
neuropathology is still to be confirmed.
ELECTROPHYSIOLOGICAL PROPERTIES
OF SOM INTERNEURONS
SOM neurons display diverse spiking responses to somatic
current injections in patch-clamp recordings. It should be
mentioned that, the same firing phenotype has variety of names
in different studies (Kawaguchi and Kubota, 1996, 1997; Gibson
et al., 1999; Beierlein et al., 2003; Goldberg et al., 2004; Wang
et al., 2004; Ma et al., 2006).
In the neocortex, the majority of SOM neurons displays so
called classical accommodating (c-AC;Wang et al., 2004) spiking
responses to current injection which might be analogous to
other terms such as regular spiking (RS) non-pyramidal (RSNP,
Kawaguchi and Kubota, 1996, 1997) or low-threshold spiking
(LTS, Kawaguchi, 1993; Gibson et al., 1999; Goldberg et al., 2004)
in other studies.
‘‘Classic’’ LTS interneurons generate rebound spike bursts
following somatic hyperpolarization (Kawaguchi and Kubota,
1996; Goldberg et al., 2004) and not every SOM cell shows
this phenomenon (Goldberg et al., 2004; Ma et al., 2006).
Additionally, in response to hyperpolarizing currents, LTS cells
display a sag which is mediated by the hyperpolarization-
activated cationic current Ih (Ma et al., 2006).
The most characteristic feature of LTS cells that distinguishes
them from RS excitatory neurons and fast spiking (FS)
interneurons is the shape of the afterhyperpolarization
(AHPs), which consists of two components with early and
late peaks (Kawaguchi, 1993; Kawaguchi and Kubota, 1996;
Beierlein et al., 2003; Ma et al., 2006), also referred as a
triphasic waveform by Ma et al. (2006). The spike-width
of SOM cells is intermediate: broader than in PV cells
and narrower than in excitatory neurons (Ji et al., 2016).
In addition, SOM neurons expressing CR have slightly
broader action potentials with slower AHPs than SOM/CR
(Xu et al., 2006).
There is also a small subset of SOM neurons (15%, Wang
et al., 2004) responding with a spike burst at the beginning
of the discharge which is called burst-accommodating (b-AC,
Wang et al., 2004) or burst spiking non-pyramidal cell (BSNP,
Kawaguchi and Kubota, 1996).
Moreover, a small fraction of SOM cells (8%, Wang et al.,
2004) shows non-accommodating firing response (NAC) which
is analogous to FS responses characteristic to PV interneurons.
Lastly, the minority of SOM neurons also shows burst irregular
spiking responses (b-IS, Wang et al., 2004) or stuttering
responses (STUT, Ma et al., 2006).
It is worthwhile to mention that VIP interneurons display
similar LTS/RSNP/BSNP firing phenotype (Kawaguchi and
Kubota, 1997). For this reason, LTS is not a definitive
determinant of SOM neurons and careful consideration should
be given to studies using the firing phenotype as the only
one category to determine a subset of interneurons since
this population might include interneurons expressing different
molecular markers.
Due to diversity in the firing pattern and also morphology
of SOM cells, considerably studies should combine
electrophysiological, morphological and molecular approaches
to reveal potential diversity within SOM interneuron population.
Generally, SOM neurons in L2/3 and L5 share similar
electrophysiological properties whereas L4 SOM neurons are
distinctive (Ma et al., 2006). SOM neurons located in L2/3 and
L5 have a very high input resistance and more depolarized
resting membrane potentials in comparison to FS interneurons,
whereas L4 SOM neurons have these membrane properties
comparable to FS (Ma et al., 2006). L5 SOM neurons respond
more frequently with the initial burst than SOM neurons in
other cortical layers and many L4 SOM neurons fire in stuttering
or FS-like pattern (Ma et al., 2006). Using SOM-Cre-mouse
line (Taniguchi et al., 2011), in which Cre recombinase is
expressed in SOM-containing neurons, Hu et al. (2013) found,
that a small portion (6–10%) of Cre+ cells displays FS firing
and expresses PV instead of SOM. It is unclear if this is
off-target recombination or a real subgroup of interneurons
expressing both SOM and PV at different developmental
stages.
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SOM neurons are highly interconnected by chemical
synapses with local excitatory neurons as well as with
different types of inhibitory neurons (Kapfer et al., 2007;
Fino and Yuste, 2011; Levy and Reyes, 2012; Pfeffer et al.,
2013; Xu et al., 2013; Jiang et al., 2015; Pala and Petersen,
2015). In addition, SOM neurons might be powerfully
involved in the synchrony and oscillatory activity of the
neuronal network by forming both electrical coupling within
the subpopulation and chemical synapses with different
neuronal subpopulations (Fanselow et al., 2008; Fanselow
and Connors, 2010; Hu and Agmon, 2015; Karnani et al.,
2016).
Both in vitro and in vivo electrophysiological recordings
have shown that excitatory synapses onto SOM neurons
are common but weaker than those formed onto PV (FS)
cells (Kapfer et al., 2007; Fanselow et al., 2008; Pala and
Petersen, 2015). However, the highly converging local excitatory
inputs together with SOM cells membrane features such
as the high input resistance, depolarized resting membrane
potential and low spike threshold can powerfully recruit SOM
cells into the network. Repetitive stimulation in a single
pyramidal neurons is sufficient to drive a SOM cell to fire
and provide feedback inhibition to pyramidal neurons in
vitro (Kapfer et al., 2007; Silberberg and Markram, 2007)
and in vivo (Gentet et al., 2012; Kwan and Dan, 2012).
This phenomenon suggests that SOM neurons might be
activated during periods of increased network activity but
interestingly, in vivo recordings in the barrel cortex shows
that activity of L2/3 SOM neurons is characterized by a high
rate of discharge during quiet wakefulness and is dramatically
reduced during active whisking or whisker deflections (Gentet
et al., 2012). A brain state in which L2/3 SOM neurons
are engaged in the network above their quiet range is
unknown (Gentet et al., 2012). Optogenetic inhibition of SOM
activity leads to an increase in the efficacy of excitatory
connections between L2/3 pyramidal neurons (Urban-Ciecko
et al., 2015) and results in the increase in burst firing
of pyramidal neurons (Gentet et al., 2012). The inhibitory
mechanism in this phenomenon involves the activity of
both GABAA and GABAB receptors (Urban-Ciecko et al.,
2015).
SOM neurons are highly active in vivo (Gentet et al.,
2012; Pala and Petersen, 2015) and in vitro (Fanselow et al.,
2008; Fanselow and Connors, 2010; Urban-Ciecko et al., 2015).
Interestingly, SOM neurons fire persistently during UPstates
and Downstates (Fanselow et al., 2008; Fanselow and Connors,
2010; Pala and Petersen, 2015; Urban-Ciecko et al., 2015)
and in fact, at least in layer 2/3 their membrane potential
fluctuation is lower and anticorrelated to other neurons during
quiet wakefulness (Gentet et al., 2012). In vitro, SOM cells
fire rhythmically and persistently in the theta-frequency range
(3–10 Hz) in the neocortex (Fanselow and Connors, 2010)
and the hippocampus (Leão et al., 2012). For this reason
these cells may be involved in learning and memory processes
because theta band EEG oscillations increase in power in the
prefrontal cortex during working memory tasks (Krause et al.,
2000).
INPUT OF SOM INTERNEURONS INTO
CORTICAL NETWORK
Somatostatin-expressing interneurons are found in all cortical
layers however, they are not a uniform group (Ascoli et al.,
2008; DeFelipe et al., 2013; Xu et al., 2013). In L2/3
and L5 the dominant type is the Martinotti cell, with
mostly vertically directed axons, diverging in cortical L1,
that target apical dendrites of pyramidal neurons (Kawaguchi
and Kubota, 1997; Wang et al., 2004). SOM interneurons
project densely to pyramidal cells located within a 200 µm
radius (Fino and Yuste, 2011), mostly target their dendritic
compartment and are recruited in a feedforward manner by
activated pyramidal neurons for which they provide feedback
inhibition (Fino et al., 2013). This circuit mediated by
Martinotti cells modulates the effects of input arriving at
apical dendrites of pyramidal neurons, thus controlling the
input to supra-and infragranular layers. Also, by inhibiting
generation of dendritic spike in L5 pyramids, they affect
the output from the cortex (Larkum et al., 1999; Goldberg
et al., 2004). The role of SOM interneurons in cortical
desynchronization was examined by Chen et al. (2015),
who stimulated intracortical cholinergic fibers. They found
that SOM activation by acetylcholine or by optogenetics is
sufficient to induce desynchronization. The study of Pfeffer
et al. (2013) provided a blueprint for cortical inhibitory
interactions. They recorded from Cre-mouse lines with ChR2
inserted in PV, SOM or VIP neurons and did single
cell molecular profiling. The interconnectivity pattern, they
found in L2/3 and L5, was that PV neurons preferentially
inhibited one another, SOM inhibited intensively VIP and
PV, but not SOM interneurons. VIP preferentially silenced
SOM neurons. Inhibition of SOM by PV neurons was
not observed. The role of SOM interneurons was also
documented in another article from Scanziani Lab (Adesnik
et al., 2012) that examined signal processing in visual
cortex of mice with respect to mechanisms of receptive
field surround suppression of pyramidal cell responses. They
found that L2/3 SOM neurons are responsible for surrounding
suppression and are activated preferentially by horizontal
axons of L2/3 pyramids. Fu et al. (2014) explored the role
of VIP-SOM circuit in mouse visual cortex in enhanced
responsiveness to visual stimulation during motion and in ocular
dominance plasticity. The disinhibitory VIP-SOM-pyramid
circuit was found to be strongly modulated by acetylcholine
acting via nicotinic receptors on VIP neurons. This circuit
was recently reported to regulate plasticity in the adult
brain.
SOM neurons with cell bodies in cortical L4 have axonal
projections focused on FS, PV-positive interneurons and—to
less extent—excitatory neurons of L4 (Xu et al., 2013).
L4 SOM neurons specific function may be the release of
thalamorecipient excitatory neurons from inhibition by PV-
containing interneurons, which results in the opening of a gating
mechanism restricting the flow of afferent information into
upper cortical layers (Xu et al., 2013). In this way, SOM neurons
control the output of L4.
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INVOLVEMENT OF INHIBITORY SOM
INTERNEURONS IN BRAIN PLASTICITY
The role of inhibitory interactions in neuroplastic changes
has been recognized recently (Kullmann et al., 2012; Griffen
and Maffei, 2014; Scheyltjens and Arckens, 2016) and in the
last few years circuits involved in mechanisms of conditioning
(Letzkus et al., 2011; Pi et al., 2013; Lovett-Barron et al.,
2014; Wolff et al., 2014) and cortical representational plasticity
(Fu et al., 2015), cortico-cortical integration (Lee et al., 2013)
were identified and characterized. It is apparent that different
interneuronal subtypes have a different role in controlling
experience-dependent plasticity and in control of the output of
principal neurons.
Robust experimental evidence exists that confirms the
participation of somatostatin and somatostatin-containing
interneurons in different forms of plasticity and memory
formation. A positive correlation between the amount of
endogenously expressed somatostatin and performance in
hippocampus-dependent learning tasks has been observed in
several studies (Nilsson et al., 1993; Nakagawasai et al., 2003).
Intracerebroventricular administration of SOM facilitated
memory (Vécsei et al., 1983, 1984; Lamirault et al., 2001)
whereas its depletion impaired passive and active avoidance
learning (Schettini et al., 1988; DeNoble et al., 1989), as well
as water maze performance (Fitzgerald and Dokla, 1989;
Guillou et al., 1998). Kluge et al. (2008) using the approach of
targeted ablation of SOM gene observed significant reduction
of long-term potentiation (LTP) in hippocampal CA1 and
concluded that somatostatin appears to be indispensable for the
acquisition of contextual fear memory. In line with this finding,
McKay et al. (2013) observed that eye-blink conditioning
results in higher intrinsic excitability of SOM interneurons
and that results in enhanced inhibition onto CA1 pyramidal
neurons.
Recently, the role of SOM neurons in motor training was
revealed by Chen et al. (2015). They provided evidence for
motor training-induced reduction in the density of cortical
SOM neurons presynaptic boutons, suggesting that the resulting
reduction in inhibition is essential for motor learning. In the
same experiment Chen et al. (2015) found that SOM neurons
were involved in regulation of dendritic spines stabilization,
so activation or inhibition of SOM cells can affect both pre-
and postsynaptic elements involved in plasticity. Optogenetic
enhancement or suppression of SOM neurons activity in the
motor cortex impaired the learning of stereotyped movements
(Chen et al., 2015).
In mouse motor cortex, SOM neurons regulated the branch-
specificity of dendritic Ca2+ spikes in L5 pyramidal neurons
during motor learning and their inactivation or deletion in
the primary motor cortex disturbed branch-specific dendritic
calcium spikes and impaired multiple motor task learning
(Cichon and Gan, 2015).
Gentet et al. (2012) and Palmer et al. (2012) considered
the role of SOM neurons in gating the top-down (attentional,
memory) inputs to the cortex. In a recent article, where
neuronal activity during prolonged visually guided active
avoidance learning was examined, Makino and Komiyama
(2015) observed that the activity of L2/3 SOM neurons
was reduced in the primary visual cortex of the mouse
after long-lasting training, when the top-down inputs from
retrosplenial cortex predominated over bottom-up visual
inputs. Activation of these neurons caused the non-SOM
neurons to respond in the manner they display at the
beginning of the training, when the bottom-up processes
dominate. The authors concluded that reduced SOM cells
activity could facilitate the effects of top-down inputs,
while enhanced activity promotes bottom–up inputs, and
so SOM neurons act as a pathway switch. A recent article
by Kato et al. (2015) demonstrated bidirectional regulation
of SOM neurons activity in auditory cortex. With the use
of chronic two-photon calcium imaging they found that
response adaptation to the repeated tone observed in L2/3
pyramidal neurons is due to upregulation of tone-evoked
responses of SOM neurons. Conversely, when the tone
acquires behavioral significance, responses of SOM neurons
are downregulated.
Involvement of SOM interneurons in neuroplasticty
has been also demonstrated in the three most popular
neuroplasticity models including ocular dominance changes,
classical fear conditioning and experience-dependent barrel
cortex plasticity. SOM neurons transplanted to adult visual
cortex trigger the second critical period, enabling cortical
plasticity and reshaping neuronal network (Tang et al.,
2014). In adult visual cortex of awake head restrained mice,
locomotion activates the VIP-SOM disinhibitory circuit which
results in a state of facilitated, enhanced ocular dominance
plasticity (Fu et al., 2015). Synaptic potentiation onto SOM
neurons in amygdala is required for the expression of
conditioned fear (Li et al., 2013; Penzo et al., 2014). Wolff
et al. (2014) showed that UCS action in fear conditioning
causes inhibition of SOM neurons in the basolateral
amygdala, and that releases dendritic domains of principal
neurons from inhibition and enhances integration of CS
and UCS inputs. In the barrel cortex, fear conditioning with
vibrissae stimulation as CS is linked to upregulation of GAD
synthesis in SOM interneurons (Cybulska-Klosowicz et al.,
2013).
SOM Interneurons in Learning–Dependent
Plasticity of the Barrel Cortex
The barrel cortex, which is the part of rodent primary
somatosensory cortex containing representation of facial
vibrissae is a widely used experimental model system for
investigating cortical structure, function and plasticity (Margolis
et al., 2014). Simple associative learning induces plasticity of
the cortical representation of vibrissae (Siucinska and Kossut,
1996). Using [14C]-2-deoxyglucose autoradiography, we found
that classical conditioning, in which the stimulation of a row
of vibrissae (CS) was paired with a tail shock (UCS), resulted
in an increase in the area of the barrel cortex activated by
the vibrissae stimulated during conditioning (Siucinska and
Kossut, 1996). In the new memory trace arising as a result
of the conditioning, this enlarged cortical representation of
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mechanoreceptors receiving the CS may act as a memory
enhancer, increasing the strength of the signal, reducing
signal to noise ratio, and may facilitate the readout from
memory.
At the same time, cortical representation expansion is
paralleled by an extensive mobilization of GABAergic system
visible in rapid increase of GAD-67 mRNA expression in L4
and increased density of GAD and GABA immunoreactive
cells in the hollows of barrels of the row receiving input
from the stimulated whiskers (Siucinska et al., 1999; Gierdalski
et al., 2001). More inhibitory synapses appeared on spines
in L4 and an increased concentration of GABA was found
in the presynaptic terminals of the synapses on disynaptic
spines (Jasinska et al., 2010). The physiological effect of
GABA-ergic upregulation, examined by intracellular recordings,
consisted in increase of frequency of spontaneous inhibitory
postsynaptic currents in excitatory neurons located in barrels
receiving the conditioned stimulus (CS; Tokarski et al., 2007).
Investigations of GABA-ergic tonic currents revealed that
they increased in excitatory L4 neurons after conditioning
but markedly decreased in fast-spiking inhibitory interneurons
(Urban-Ciecko et al., 2010). Reducing GABA synthesis during
conditioning by intracortical injections of GAD inhibitor
blocked formation of plastic change of whisker representation
(Posluszny et al., 2015). The results listed above speak for
modifications of inhibitory interactions in the cortex that is
reorganized by the conditioning, and also for necessity of
inhibition within the mechanism of learning-induced plastic
change. Immunocytochemical examination of several GABA-
ergic interneuron subtypes (SOM+, CR+, PV+, CB+) found
an increase in the density of SOM+/GAD+ neurons in L4 of
the plastic representation of the stimulated row of whiskers
(Cybulska-Klosowicz et al., 2013).
Most of L4 SOM neurons belong to a different subgroup than
the extensively studied Martinotti cells. SOM cells of cortical L4
have a different morphology, with the axon confined to L4 where
it forms dense arborizations (Ma et al., 2006; Xu et al., 2013).
They make up about 20–30% of L4 inhibitory interneurons
(Rudy et al., 2011). The thalamic input to SOM neurons is weak
and depressing, and the afferent sensory information to SOM
cells comes through principal neurons (Beierlein et al., 2003;
Cruikshank et al., 2010; Xu et al., 2013). L4 SOM interneurons
can fire at much higher frequencies than those of L2/3. Xu et al.
(2013) documented opposite effect of optogenetic supressing
SOM cells in L2/3 than in L4 (enhancement and suppression of
local excitatory neurons firing, respectively) in brain slices during
UP states. It is possible that these populations of interneurons
have different effects on plasticity also in awake and attentive
animal. In L4, the connection probability of SOM cells with
PV-expressing interneurons is higher than their connection
probability with principal neurons, and they weakly inhibit
principal neurons, but have strong inhibitory action upon FS
(PV) neurons (Xu et al., 2013). In this way they decrease
feedforward inhibition exerted by FS cells on principal neurons
and disinhibit transmission of the afferent signal from the
thalamus (Xu et al., 2013).
Why is GAD Upregulated in Layer 4 SOM
Neurons, and What Role can They Play
During Conditioning?
We showed that the GAD upregulation was specific to mice
that were conditioned and not seen in the group that received
only CS, only UCS, or pseudoconditoning, so the crucial
factor is the simultaneous action of CS and UCS (Siucinska
and Kossut, 2006). In our experiments this lasts 0.5 s and
should bring about an interaction of the CS afferent pathway
with ascending neuromodulatory projections activated by the
UCS. Letzkus et al. (2011) have shown that associative fear
learning requires the cholinergic input to the cortex from
nucleus basalis. They documented that cholinergic activation
of L1 inhibitory interneurons generated inhibition of L2/3 PV
inhibitory interneurons that resulted in disinhibiton of L2/3
pyramidal neurons in the sensory cortex. Since afferents from
the basal forebrain also reach cortical L4 (Mesulam et al., 1983),
it is plausible that in our conditioning paradigm information
about aversive stimulus modifies the reception of CS in the
thalamorecipient L4. The study of Cybulska-Klosowicz et al.
(2013) showed that SOM neurons may contribute to this process.
As described in the previous chapter, L4 SOM neurons can
decrease the feedforward inhibition exerted by FS cells on
principal (excitatory) neurons and thus disinhibit transmission
of the afferent signal from the thalamus (Xu et al., 2013). Possibly,
in response to conditioned sensory stimulus (whisker activation)
and UCS (tail shock), the L4 SOM containing inhibitory network
could supplement this disinhibitory effect from the L4 level,
(Figure 1A) more effectively removing feed-forward inhibition
of excitatory neurons during sensory input. In this way, the
hypothetical mechanism of CS and UCS action upon L4 circuitry
would consist in removing of gating of thalamocortical signal
by PV interneurons (Figure 1B). PV interneurons inhibit, by a
feedforward loop, L4 excitatory neurons, restricting their output
to upper cortical layers and to SOM cells in L4. UCS-driven
cholinergic projection to the cortex acts on PV cells synapses
onto principal neurons via inhibitory M2 cholinergic receptors,
effectively weakening the inhibition of principal cells by PV
neurons (Kruglikov and Rudy, 2008). Cholinergic input to SOM
interneurons, via both muscarinic and nicotinic receptors, is
effective at much lower agonist doses than in other interneurons
(Chen et al., 2015). Unlike PV cells, SOM neurons are activated
by acetylcholine, and their activation contributes to inhibition of
PV interneurons and consequently to disinhibition of principal
cells. Freed from afferent inhibition by PV neurons, principal
cells can in turn activate SOM cells, which would then more
strongly inhibit PV neurons. This disinhibition (SOM-PV) in the
thalamocortical input layer during CS+UCS pairing may allow
for wider spreading of the signal from the active vibrissae in the
barrel cortex (Figure 1B). Slow acting co-release of somatostatin
is likely to enhance and prolong the inhibitory action of GABA
released from SOM axons upon PV neuron thereby lengthening
the thalamocortical gate opening period.
Activation of SOM cells during CS+UCS pairing may lead
to the activity-dependent upregulation of GAD synthesis in
this subtype of interneurons, resulting in the increased density
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FIGURE 1 | During conditioning somatostatin (SOM) interneurons of layer 4 (L4) regulate thalamocortical input gate operated by parvalbumin (PV)
interneurons. (A) Before conditioning. During tactile stimulation of vibrissae the input from ventrobasal nucleus of thalamus targets principal cells and PV
interneurons. PV interneurons by feedback inhibition control output of principal cells. Principal cells activate SOM interneurons, which inhibit PV interneurons. The
input from nucleus basalis to SOM and PV neurons is weak. (B) Cholinergic effects during conditioning. Pairing tactile stimulus with a tail shock stimulate
acetylcholine release from nucleus basalis afferents, which inhibits PV—principal cell synapse by M2 receptors, and activates SOM interneurons by nicotinic
receptors. Strong activation of SOM interneurons (by principal cell and Ach) results in increased inhibition of PV interneurons and facilitates opening the
thalamocortical input gate so that signal from vibrissae stimulated in conditioning achieves stronger excitation of the barrel cortex. Abbreviations: Ach, acetylcholine;
CS, conditional stimulus; PC, principal cell; PV, parvalbumin-containing interneuron; PYR, pyramidal neuron; SOM, somatostatin-containing interneuron; UCS,
unconditional stimulus.
of SOM+/GAD+ cells that was observed at 24-h post-training
(Cybulska-Klosowicz et al., 2013). Such up-regulation of GAD
synthesis by neural activity has been demonstrated previously
(Welker et al., 1989; Knott et al., 2002). Somatostatin levels are
also activity-regulated (Hou and Yu, 2013). These two metabolic
processes may explain the increased density of SOM+/GAD+
cells observed after conditioning within the plastic cortical
representation.
SUMMARY
Availability of long-acting agonist and use of genetically
modified mice has increased our understanding of somatostatin
function and its role in regulation of brain activity. However,
simultaneously, a complexity of possible somatostatin effects
and identification of distinct subpopulation of somatostatin-
containing interneurons with characteristic electrical profile
and specific anatomical features increased a diversity of
somatostatinergic system activation outcome. SOM interneurons
were shown to be involved in motor activity, sleep, sensory
processes, cognitive functions, neuronal plasticity, while its
alterations are implicated in many brain diseases like affective
disorders, epilepsy or AD. Thus, despite several decades of
investigations, somatostatinergic system still keeps its secrets.
Regardless increasing knowledge concerning the location,
distribution and action, much remains to be learned about
the ways that somatostatin works and interacts with classical
neurotransmitters to modulate excitability of target cells and
shape the response of the neuronal networks.
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